U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Bexagliflozin

Last Revision: September 15, 2023.

Estimated reading time: 1 minute

CASRN: 1118567-05-7

image 391700990 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the clinical use of bexagliflozin during breastfeeding. Bexagliflozin is 93% protein bound in plasma, so it is unlikely to pass into breastmilk in clinically important amounts. The manufacturer does not recommend bexagliflozin during breastfeeding because of a theoretical risk to the infant's developing kidney. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Acarbose, Glipizide, Glyburide, Insulin, Metformin, Miglitol

Substance Identification

Substance Name

Bexagliflozin

CAS Registry Number

1118567-05-7

Drug Class

Breast Feeding

Lactation

Milk, Human

Hypoglycemic Agents

Sodium-Glucose Cotransporter 2 Inhibitors

SGLT2 Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK594973PMID: 37748011

Views

Related information

Similar articles in PubMed

  • Review Dapagliflozin.[Drugs and Lactation Database (...]
    Review Dapagliflozin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Empagliflozin.[Drugs and Lactation Database (...]
    Review Empagliflozin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Ertugliflozin.[Drugs and Lactation Database (...]
    Review Ertugliflozin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Lovastatin.[Drugs and Lactation Database (...]
    Review Lovastatin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Canagliflozin.[Drugs and Lactation Database (...]
    Review Canagliflozin.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...